Position history for STIFEL FINANCIAL CORP's holdings in ARROWHEAD PHARMACEUTICALS IN
STIFEL FINANCIAL CORP holds 11,811 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $784,130 as of 2025-Q4. This is a new position. ARWR represents 0.0% of STIFEL FINANCIAL CORP's portfolio.
Current Value
$784,130
Current Shares
11,811
Total Value Change
$0
Total Shares Change
0
Other major holders of ARWR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
New |
| 11,811 |
- |
| $784,130 |
| 0.0% |
| $67.25 |
34 |